Mark Klein currently serves as a Senior Research Scientist in the Advanced Technologies Group at Promega Corporation, a position held since December 2020. Prior experience includes roles as Research Scientist 4 and Postdoctoral Researcher at the University of Wisconsin-Madison from August 2014 to December 2020, focusing on enhanced SIRT6 catalysis under the guidance of Professor John Denu. Mark Klein also completed an R&D Research Internship at Promega Corporation in 2018 and contributed to NMR lab maintenance at the University of Illinois at Urbana-Champaign from May 2012 to May 2014. An undergraduate research assistant at the University of Illinois, Mark Klein earned a Bachelor of Science in Biochemistry in 2014, followed by a Doctor of Philosophy in Biochemistry from the University of Wisconsin-Madison in 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices